Clinical Trial Update: A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax Combined With Chemotherapy in Participants With B-Cell Non-Hodgkin's Lymphoma (NHL) and DLBCL [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating venetoclax with chemotherapy in B-cell non-Hodgkin lymphoma and diffuse large B-cell lymphoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Venetoclax (venetoclax)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Lymphoma, Non-Hodgkin | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-12-20